BamSEC and AlphaSense Join Forces
Learn More

Gyre Therapeutics Inc.

NASDAQ: GYRE    
Share price (12/24/24): $11.90    
Market cap (12/24/24): $1.113 billion
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 8-K/A 16 pages Employment Agreement
12/34/56
EX-10.2
from 8-K 8 pages Separation Benefits
12/34/56
EX-10.1
from 8-K 7 pages October 30, 2023 Dr. Nassim Usman, PH.D. 965 Elsinore Drive Palo Alto, Ca 94303 Re: Separation Agreement
12/34/56
EX-10.5
from 8-K 16 pages Employment Agreement
12/34/56
EX-10.4
from 8-K 16 pages Employment Agreement
12/34/56
EX-10.3
from 8-K 11 pages Indemnification Agreement
12/34/56
EX-10.2
from 8-K 22 pages Gyre Therapeutics, Inc. 2023 Omnibus Incentive Plan
12/34/56
EX-10.1
from 8-K 25 pages Securities Purchase Agreement
12/34/56
EX-10.4
from 10-Q 7 pages Catalyst Biosciences, Inc. January 17, 2023
12/34/56
EX-10.3
from 10-Q 7 pages Catalyst Biosciences, Inc. January 14, 2023
12/34/56
EX-10.2
from 10-Q 8 pages Catalyst Biosciences, Inc. January 17, 2023
12/34/56
EX-10.4
from 10-Q 6 pages Catalyst Biosciences, Inc. January 17, 2023
12/34/56
EX-10.3
from 10-Q 6 pages Catalyst Biosciences, Inc. January 14, 2023
12/34/56
EX-10.2
from 10-Q 7 pages Catalyst Biosciences, Inc. January 17, 2023
12/34/56
EX-10.1
from 8-K 42 pages Asset Purchase Agreement
12/34/56
EX-10.1
from 425 13 pages Indemnification Agreement
12/34/56
EX-10.1
from 8-K 13 pages Indemnification Agreement
12/34/56
EX-10.2
from 8-K 3 pages Amendment to Employment Agreement
12/34/56
EX-10.1
from 8-K 7 pages 4 November 2021 Seline Miller 16050 Harwood Road Los Gatos, Ca 95032 Dear Ms. Miller
12/34/56
EX-10.8
from 10-K 8 pages Catalyst Biosciences Inc. 2018 Omnibus Incentive Plan Notice of Stock Option Award
12/34/56